Ladenburg Thalmann Downgrades ReShape Lifesciences Inc (RSLS) to Neutral
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/21/2026
- Wall Street sinks as bond yields rise, Walmart results disappoint
- Walmart shares fall despite earnings beat
- Alibaba stock dips as Q2 profit misses estimates despite strong AI cloud growth
- Wolfe remains "broadly bullish on AI semis stocks", names Top Pick
- Moderna stock pulls back after massive one-day rally: analysts weigh in
- Wall Street sinks as bond yields rise, Walmart results disappoint
- Wolfe remains "broadly bullish on AI semis stocks", names Top Pick
- Supermicro probe finds no senior management link to export violations
- SpaceX shares fall as second lockup period ends
- Hertz Global amends voting agreement with CK Amarillo after lawsuit
ReShape Lifesciences Inc. (RSLS) Prices 1M Share Registered Direct Offering at $0.60/Sh
August 2, 2018 7:55 AM EDTReShape Lifesciences Inc. (NASDAQ: RSLS) today announced that it has entered into definitive agreements with several institutional investors for the purchase of 1,000,000 shares of its common stock, at a purchase price per share of $0.60, for gross proceeds of approximately $0.6 million, in a registered direct offering.... More
